Visual impairment due to age-related macular degeneration during 40 years in Finland and the impact of novel therapies.

ABSTRACT:

Purpose

To evaluate the changes in visual impairment (VI) due to age-related macular degeneration (AMD) during the past 40 years and the impact of novel therapies at population level.

Methods

In this nationwide register-based study, we assessed the incidence, prevalence, severity, and onset age of VI due to AMD based on the Finnish Register of Visual Impairment data from 1980 to 2019. Our data included 30 016 visually impaired persons with AMD as the main diagnosis for VI. The number of persons treated with intravitreal injections in Finland was obtained from hospital data kept by the Finnish Institute for Health and Welfare.

Results

Between the 1980s and the 2010s, the incidence of reported VI doubled; however, this increase has stagnated in the 2010s. Since 2012, th

SUBMITTER: Purola P 

PROVIDER: S-EPMC10087211 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature